Introduction
============

Ubiquitination is a major form of post-translational modification that regulates essentially all aspects of cellular functions [@B1]. Conjugation of ubiquitin to a protein is carried out by sequential actions of three enzymes: an ubiquitin activating enzyme (E1), an ubiquitin conjugase (E2), and an ubiquitin ligase (E3). Because of diverse functions and physical contact with substrates, E3 ubiquitin ligases are of the most importance. Smurf1 and Smurf2 are two closely related members of the HECT family of ubiquitin E3 ligases, sharing a high degree of amino acid sequence homology and distinctive structural features of the HECT family of E3 ubiquitin ligases. These features include an amino-terminal phospholipid/calcium-binding C2 domain, two to four copies of WW repeats that mediate protein-protein interactions by binding to a PPXY (PY) motif in target proteins, and a carboxyl-terminal HECT domain that catalyzes the ubiquitination reaction [@B2]. Smurfs were initially recognized as a negative regulator of TGF-β/BMP signaling through interacting with PY motifs in most R-Smads and inhibitor Smads, thereby ubiquitinating Smads, or TGF-β/BMP or targeting other downstream components of the pathway [@B3]-[@B7]. Subsequent biochemical studies broadened the repertoire of Smurf substrates to include Axin, Ezh2, ID1/ID3, KLF5, MEKK1, Ptch1, Prickle1, RhoA, RNF20, Runx2/3, Talin, Traf4, *etc.*, and extended their function to controlling cell polarity, differentiation, genomic stability and tumorigenesis [@B8]-[@B11].

To investigate the functions of Smurfs in vivo under physiological settings, mouse models with genetic modification of Smurf1 and Smurf2 have been generated [@B9], [@B12], [@B13]. In these conventional knock-out mice, *Smurf1* or *Smurf2* is disrupted in all cells, which prevents the effort for further studying of the role of Smurfs in specific types of cells and their corresponding cellular and molecular mechanisms. Furthermore, although mice that lack either *Smurf1* or *Smurf2* are viable, loss of both *Smurfs* leads to early embryonic lethality [@B9], [@B12], [@B13], which prevents us from studying the role of Smurfs in later embryonic development and diseases in adult stages such as aging related diseases. To overcome these disadvantages, we have generated a *Smurf2* conditional null allele, the *Smurf2^flox^* allele, using the Cre/LoxP system.

Materials and Methods
=====================

Generation of the *Smurf2^floxneo^* targeting construct
-------------------------------------------------------

The targeting vector was constructed using *Smurf2* genomic DNA isolated previously [@B12] and ploxPneo vector that contains a *PGKneo* cassette with two loxps at its both ends [@B14]. Briefly, a loxp site was first inserted into Smurf2 genomic DNA before the exon9, then a 7.96-kb *Xba* I fragment including exon 8-10 and flanking introns was inserted into the ploxPneo vector to generate the 5\' homology recombination arm. The 3\' homology recombination arm in the targeting vector was generated by inserting the 3.92-kb *Xba* I-*BamH* I fragment including exon 11 and flanking introns. The finished targeting construct, pLoxP-*Smurf2^floxneo^*, is shown in Figure [1](#F1){ref-type="fig"}A.

Transfection of ES cells and generation of germline chimeras
------------------------------------------------------------

TC1 embryonic stem (ES) cells [@B15] were transfected with NotI-digested pLoxP-*Smurf2^floxneo^* by electroporation and selected using G418 and -(2-deoxy-2-fluoro-β-D-avabinofuranosyl-*S*-iodouracil (FIAU). G418- and FIAU- double resistant ES clones were screened for homologous recombination events within the *Smurf2* locus by PCR. The 5\' recombination was identified by PCR using the primer p1:( 5\'- *GCTTAGTGACCAAGTAGCAC* -3\') and p2:( 5\'- *CCAGACTGCCTTGGGAAAAGC*-3\'), which generated an 8.2-kb product. The 3\' recombination was identified by PCR using the primer p3: (5\'- *CAGCTCATTCCTCCCACTC ATG* -3\') and p4: (5\'- *TCCTTTGCCTCCCAAGACTG* -3\'), which generated a 4.2-kb product. The targeted sites and integration of three Loxp sites were also confirmed by sequencing the above PCR products. Recombinant ES cells heterozygous for the targeted mutation were microinjected into blastocysts from C57/B6 mice to obtain germ-line transmission following standard procedures. The F1 agouti offspring were generated from breeding chimeric male with C57BL/6 female, and the presence of the *Smurf2^floxneo^* allele were analyzed by PCR. All mice were maintained and handled according to protocols approved by the Animal Care and Use Committee of the National Cancer Institute and National Institute of Diabetes, Digestive and Kidney Diseases, NIH.

Establish a conditional allele for *Smurf2* and genotype analysis
-----------------------------------------------------------------

To establish exon 9 and exon 10 floxed Smurf2 allele, Neo cassette were removed by crossing mice with targeted allele with *Ella-Cre* transgenic mice [@B16]. Genotypes of the mice bearing the *Smurf2^∆^*, *Smurf2^neofloxed^*, *Smurf2^flox^* and wild-type allele were determined by PCR analysis as illustrated in Figure [2](#F2){ref-type="fig"}. The primer sequences are: p5: 5\'- GATTGCAGGTTTGTGACACC-3\', p6: 5\'- AGACAACTCAGAGGAAGAGG, p7: 5\'- GAGGTCAGGGATGATTTT GG, p8: 5\'- ACAAGGGTTTACCAGTGCTC. Genomic DNA from *Smurf2^flox/flox^* mice were sequenced to confirm correct targeted sites and two LoxP sites after removing of the Neo cassette. Mice carrying *Alb-Cre* were purchased from Jackson Labs ([www.jax.org/strain/003574](http://www.jax.org/strain/003574)). The *Cre* transgene was detected using primer set of 5\'- *CCTGTTTTGCACGTTCACCG*-3\' and 5\'- *ATGCTTCTGTCCGTTTGCC G* -3\'.

Isolation of mouse embryonic fibroblasts (MEFs)
-----------------------------------------------

Embryonic fibroblasts were generated by standard techniques. Briefly, E14.5 embryos were dissected individually, all inner organs, head, limb and tail removed and remaining tissues minced by cutting. After incubation in 2.5 ml trypsin at 37°C for 5-10 minutes, cells were resuspended and plated on 10 cm plates in DMEM supplemented with 10% FBS. After three passages, homogenous fibroblast cells were apparent and used for experiments.

Adenovirus infection of MEFs
----------------------------

Recombinant adenoviruses, *Ad-GFP* and *Ad-Cre* were obtained from Vector BioLabs (Malvern, PA). Infection of MEFs was conducted in 6-well plates in DMEM supplemented with 5% FBS at a multiplicity of infection (MOI) of 100. After 24 hours of infection, cells were recovered in the regular culture medium for additional 24 hours. Cells were then treated with TGF-β (4 ng/ml) or BMP2 (100 ng/ml), BMP4 (50 ng/ml) for 1 hour after being starved for 2 hours in DMEM containing 0.2% FBS.

Western blot
------------

MEFs grown on six wells were harvested in lysis buffer containing 25 mM Tris-HCl, pH 7.5, 300 mM NaCl and 1% Triton with protease and phosphatase inhibitors. Tissues were minced by a Dounce homogenizer using 1-2 ml RIPA buffer. A total of 30 µg of protein were separated on 10% SDS-PAGE and transferred to PVDF membranes. After blocking of the membranes by 5% dry milk/TTBS, membranes were incubated in following primary antibody solutions: anti-Smurf1 (Novus, 1D7); anti-Smurf2 (Abcam, EP629Y3); anti-Smad1 (Cell Signaling, 9743); anti-Smad2 (Abcam, EP784Y); anti-Smad3 (Abcam, ab28379), anti-Smad5 (Abcam, EP619Y), anti-phospho-Smad1/5 (Cell Signaling, 41D10), anti-phospho-Smad2 (Cell Signaling, 138D4); anti-phospho-Smad3 (Rockland, 600-401-919), GAPDH (Santa Cruz, 0411), HSC70 (Santa Cruz, B-6). Protein detection was carried out using HRP-coupled species-specific secondary antibodies and ECL solution, exposed to Hyperfilm ECL.

Luciferase reporter assay
-------------------------

TGF-β (CAGA~12~-Luc), BMP4 (BRE-Luc), Sonic hedgehog (Shh) (8XGli-Luc) and Wnt-3a (TOPflash) reporter assays were carried out in MEFs. After transfected with the firefly luciferase reporters and the Renilla luciferase control reporter and incubated for 24 hours, *Smurf2^flox/flox^* or *Smurf1^-/-^;Smurf2^flox/flox^* MEFs were infected with either control adenovirus expressing LacZ or adenovirus expressing Cre for 2 days, and treated with different ligands for 16 hours. The signal of firefly luciferase was normalized to that of Renilla luciferase. The fold activation was calculated with dividing the relative luciferase unit (RLU) of the treated group by that of the untreated group. Results are shown as relative fold change ± S.D. (error bars) (n = 3 or 4).

Results and Discussion
======================

To construct the *Smurf2^floxneo^*allele, we have made a targeting vector that contains three *Loxp* sites, the first two Loxp sites flanking the entire exons 9 and 10 (Figure [1](#F1){ref-type="fig"}A). In this way, existence of *Cre* recombinase would lead to deletion of exons 9 and 10, and create a premature stop codon that terminates protein translation prior to the last two highly conserved WW domains and the HECT ubiquitin ligase domain. This targeting strategy is the same as the conventional Smurf2 knockout mice that we generated previously, in which the expression of the truncated peptide is very low and does not have a dominant function [@B12]. The neo cassette was flanked by the last two Loxp sites, which enable us to remove the neo cassette by Cre recombinase as well. After transfecting the *Not* I-linearized targeting vector pLoxP-*Smurf2^floxneo^* into TC1 ES cells, four targeted ES clones were detected by PCR (Figure [1](#F1){ref-type="fig"}B and [1](#F1){ref-type="fig"}C) and confirmed by sequencing. Two positive ES clones were microinjected into blastocysts harvested from C57/BL6 mice to generate male chimeric mice, which were bred with female C57BL/6 mice to produce F1 agouti offsprings carrying one copy of the targeted *Smurf2^floxneo^* allele.

To test whether *neo* gene and exons 9-10 in *Smurf2^floxneo^* allele can be deleted by the *Cre* recombinase and to generate a neo-less conditional knockout allele, heterozygous (*Smurf2^floxneo/+^*) mice were crossed with *EIIa-Cre* transgenic mice that express *Cre* recombinase in germline [@B17]. The offspring were identified by PCR with primers shown in Figure [2](#F2){ref-type="fig"}A. As expected, we found that this crossing breeding generated three types of alleles due to *Cre*-mediated recombination among three *Loxp* sites. A 464 bp fragment was amplified from *Smurf2^Δ^* allele with deletion of *neo* gene and exons 9-10 between *Loxp1* and *Loxp3* (Figure [2](#F2){ref-type="fig"}B). *Smurf2^neofloxed^* allele with deletion of exons 9-10 was detected by producing an amplified 170 bp fragment (Figure [2](#F2){ref-type="fig"}C). The PCR-amplified 656 bp fragment indicated the excision of the *neo* gene, which produced *Smurf2^flox^* allele (conditional knockout allele) in *Smurf2^flox/+^* heterozygous mice (Figure [2](#F2){ref-type="fig"}D).

To verify gene inactivation in tissue specific manner in mice, we generated homozygous *Smurf2^flox/flox^* mice, then crossed them with mice that carry an *Alb-Cre* transgene [@B18] to assess the activity of *Smurf2* conditional knockout allele in liver tissues (Figure [3](#F3){ref-type="fig"}A). Western blot analysis indicated that the *Cre*-mediated deletion occurs only in liver tissue, but not in other tissues where the *Alb-Cre* transgene is not expressed, such as the kidney, spleen, heart and muscle (Figure [3](#F3){ref-type="fig"}A). These data indicate that the *Smurf2^flox^* allele can be recombined to delete exons 9-10 in a tissue-specific fashion, thus the Smurf2 conditional mouse model should be very useful for studying Smurf2 functions during later stages of embryonic development. Like the Smurf2 knockout mice [@B19], histological analysis of H&E stained liver sections also did not reveal any apparent phenotype up to 12 months of age (data not shown). In addition, the liver function and lipid metabolism in these hepatocyte-specific Smurf2 knockout mice, (*Alb-Cre;Smurf2^flox/flox^* or LKO), were normal (Figure [3](#F3){ref-type="fig"}B).

We also isolated MEFs from*Smurf2^flox/flox^*embryos. After infection of these MEFs with a control adenovirus expressing GFP (*Ad-GFP*) or adenovirus expressing Cre recombinase (*Ad-Cre*), we obtained the control wild type MEFs regarding to Smurf2 expression, *Ad-GFP;Smurf2^flox/flox^*, and MEFs with Smurf2 deficiency, *Ad-Cre;Smurf2^flox/flox^* (Figure [4](#F4){ref-type="fig"}A). We treated these cells with TGF-β, BMP2 or BMP4, and did not observe any significant difference in Smad protein level or p-Smad levels among these cells (Figure [4](#F4){ref-type="fig"}A and [4](#F4){ref-type="fig"}B). However, when subjected to reporter assays, we found that TGF-β-dependent (CAGA)~12~-Luc activity were much higher in *Smurf2* deficiency MEFs (Figure [4](#F4){ref-type="fig"}C). These results were consistent with previous reports that Smurf2 does not directly target TGF-β family of receptors or Smads for polyubiquitination and degradation, instead it regulates the sensitivity of the TGF-β family signaling via monoubiquitination that disrupts formation of Smad complex [@B12], [@B20]. Smurfs were also reported to regulate many different pathways other than TGF-β and BMPs. For example, in sonic hedgehog (Shh) pathways, Smurfs promote Ptch1 to undergo polyubiquitination and degradation, thereby, activate Gli1-mediated transcription [@B10]; while in canonical Wnt signaling, Smurf1 and Smurf2 were shown to mediate ubiquitination of Axin, a negative regulator of Wnt/β-catenin signaling [@B21], [@B22]. We found that Smurf2 deficiency severely inhibited Shh-mediated Gli1-dependent 8xGli1-Luc activity and Wnt3-mediated β-catenin/Tcf reporter TOPFLASH activity (Figure [4](#F4){ref-type="fig"}D).
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![**Generation of the *Smurf2^floxneo^* allele.** (**A**) Strategy for generating the *Smurf2* targeting vector and *Smurf2^floxneo^* (targeted) allele. Blue boxes represent exons. B, BamHI; X, XbaI; H, HpaI; N, NotI; p, primer. (**B**) PCR analysis of genomic ES cell DNAs for targeted events at 3\' arm using primer p3 and p4. (**C**) PCR analysis of recombination events at 5\' arm using primer p1 and p2.](ijbsv14p0542g001){#F1}

![**Validation of exons 9-10 and neo gene in *Smurf2^floxneo^* targeted alleles deleted by Cre recombinase.** (**A**) Map of *Smurf2^floxneo^* allele. The position of primers was marked in the map. (B-D) Mice containing *Smurf2^floxneo^* alleles were crossed with *EIIa-Cre* transgenic mice resulting in three kinds of deletion between three Loxp sites. Position of primers was also marked. (**B**) Primer p5, p6 and p8 amplify fragments of 456 bp from *Smurf2^∆^* allele with deletion exons 9-10 and neo cassette between Loxp1 and Loxp3 (Loxp1/3), and a 197 bp fragment from the wild type (WT) allele. (**C**) Primer p2, p5 and p6 amplify fragments of 170 bp from *Smurf2^neoflox^* allele with deletion exons 9-10 between Loxp1 and 2 (2/3), and a 197 bp fragment from the WT allele. (**D**) Primer p7 and p8 amplified a 656 bp fragment from *Smurf2^flox^* allele with deletion neo between Loxp2 and 3 (Loxp2/3), and a 548 bp fragment from the WT allele.](ijbsv14p0542g002){#F2}

![**Generation of liver specific *Smurf2* knockout mice.** (**A**) Liver-specific inactivation of the *Smurf2* conditional allele by *Alb-Cre* transgene was revealed by Western blot analysis of liver extracts from homozygous *Smurf2^flox/flox^* or LKO (*Alb-Cre;Smurf2^flox/flox^*) mice. (**B**) No significance difference was observed in liver function: albumin, alanine transaminase (ALT) and aspartate transaminase (AST), or serum lipid content: triglyceride and cholesterol, between male adult *Smurf2^flox/flox^* and LKO mice.](ijbsv14p0542g003){#F3}

![**Multiple signaling pathways were affected by *Smurf2* deficiency.** MEFs from *Smurf2^flox/flox^* embryos were infected with adenovirus expressing Cre to remove *Smurf2* alleles. Control cells were infected with adenovirus expressing GFP or LacZ. (**A-B**) *Smurf2* deficiency did not affect Smad protein level or ligand-stimulated C-terminal Smad phosphorylation in MEFs. Cells were treated with (A) TGF-β or (B) BMP-2 or BMP-4 for 1 hour. Whole cell lysates were subjected to Western blot analysis using specific antibodies as indicated. (**C**) *Smurf2* deficiency significantly increased TGF-β (CAGA~12~-Luc)-dependent transcription reporter activities, but not much on BMP (BRE-Luc)-dependent activities. (**D**) *Smurf2* deficiency inhibited Shh-induced 8xGli1-Luc and Wnt3A-induced TOPFLASH reporter activities. Results are shown as relative fold change ± S.D. (error bars) (n = 3 or 4). Statistically significant difference (*p* \< 0.01) after ligand treatment is indicated by \*; statistically significant differences (p \<0.01) between control and Smurf2 deficient cells after ligand treatment are indicated by \#, respectively.](ijbsv14p0542g004){#F4}
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